CSI Market
Sign In | Register

Bioxytran Inc (BIXT) Annual Balance Sheets

Annual · GAAP · USD millions
Access BIXT quarterly Balance Sheets →
Looking at balance sheet data from Bioxytran Inc through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.51
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.00
Total Current Assets0.51
Intangible Assets0.15
Other Assets, Noncurrent0.00
Total Assets0.66
Liabilities
Accounts Payable1.50
Derivative Liability, Current DE0.40
Short-term Debt0.40
Other Liabilities, Current0.87
Deferred Compensation Share-based Arrangements, Liability, Current DE10.08
Total Current Liabilities3.25
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Unissued Shares Liability Related Party Current0.00
Total Liabilities3.25
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock18.30
Retained Earnings / Accumulated Deficit-21.04
Other Equity0.00
Common Stockholder's Equity-2.63
Preferred Stockholder's Equity0.04
Non-controlling interests & other0.00
Total Stockholder's Equity-2.59
Liabilities & Stockholder's Equity0.66
4 historic quarters locked

Sign in to unlock the full Bioxytran Inc balance sheet history.

Sign In Create Free Account

About Bioxytran Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 15, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-016798

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License